Specifically, individuals with the PNPLA3 rs738409 CC and CG genotypes demonstrated a reduction in intestinal Blautia and Ruminococcaceae, potentially amplifying the role of microbiota in the onset and progression of MASLD [81]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.